Cargando…
Design of drug-like hepsin inhibitors against prostate cancer and kidney stones
Hepsin, a transmembrane serine protease abundant in renal endothelial cells, is a promising therapeutic target against several cancers, particularly prostate cancer. It is involved in the release and polymerization of uromodulin in the urine, which plays a role in kidney stone formation. In this wor...
Autores principales: | Blay, Vincent, Li, Mu-Chun, Ho, Sunita P., Stoller, Mashall L., Hsieh, Hsing-Pang, Houston, Douglas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7452031/ https://www.ncbi.nlm.nih.gov/pubmed/32874830 http://dx.doi.org/10.1016/j.apsb.2019.09.008 |
Ejemplares similares
-
Venetoclax is a potent hepsin inhibitor that reduces the metastatic and prothrombotic phenotypes of hepsin-expressing colorectal cancer cells
por: Rodenas, Maria Carmen, et al.
Publicado: (2023) -
Clinical Significance of Hepsin and Underlying Signaling Pathways in Prostate Cancer
por: Lu, Lucy, et al.
Publicado: (2022) -
Kidney stone disease
por: Chi, Thomas, et al.
Publicado: (2014) -
HEV-ORF3 Encoding Phosphoprotein Interacts With Hepsin
por: Wang, Chunyan, et al.
Publicado: (2014) -
Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis
por: Tang, Xi, et al.
Publicado: (2014)